| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/06/2011 | US20110002988 Orally rapidly disintegrating tablet comprising imidafenacin |
| 01/06/2011 | US20110002908 Treatment of a-galactosidase a deficiency |
| 01/06/2011 | CA2767130A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones |
| 01/05/2011 | EP2270049A2 Recombinant anti-interleukin-9-antibody |
| 01/05/2011 | EP2270047A2 Anti-C5 antibodies and their therapeutic uses |
| 01/05/2011 | EP2270046A2 Methods and compositions for the treatment of hemolysis-associated diseases |
| 01/05/2011 | EP2270005A1 Prodrug of an ice inhibitor |
| 01/05/2011 | EP2269989A1 Iminopyridine derivative and use thereof |
| 01/05/2011 | EP2268273A1 Small-molecule modulators of trp-p8 activity |
| 01/05/2011 | EP2268141A1 Compounds and method for reducing uric acid |
| 01/05/2011 | EP2076508B1 Biaryl ether urea compounds |
| 01/05/2011 | EP1680110B1 Once daily dosage forms of trospium |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | EP1437043B1 Rat model with overexpression of regucalcin |
| 01/05/2011 | CN101935315A Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 01/05/2011 | CN101934004A Chinese herbal medicament for treating urinary infections |
| 01/05/2011 | CN101933980A Capsule preparation for treating nephritis associated with hepatitis B and preparation method thereof |
| 01/05/2011 | CN101933979A Traditional Chinese medicinal composition for treating calculus |
| 01/05/2011 | CN101623271B Compound alpha-keto acid dispersible tablet |
| 01/05/2011 | CN101579395B Traditional Chinese medicine for treating kidney weakness |
| 01/05/2011 | CN101485735B Medicament composition with stone-eliminating and expelling functions and preparation method thereof |
| 01/05/2011 | CN101317875B Cornus officinalis processing method |
| 01/05/2011 | CN101224226B Novel clinical uses of big nilgiri nettle |
| 01/04/2011 | US7863475 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/04/2011 | US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 01/04/2011 | US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders |
| 01/04/2011 | US7863047 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/04/2011 | CA2558191C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 01/04/2011 | CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 01/04/2011 | CA2483590C Use of inhibitors of egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (bph)/prostatic hypertrophy |
| 01/04/2011 | CA2462953C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
| 01/04/2011 | CA2430279C Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treatment of urinary incontinence |
| 01/04/2011 | CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives |
| 01/04/2011 | CA2389544C Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 12/30/2010 | US20100331406 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 12/30/2010 | US20100331395 Decoy-containing pharmaceutical compositions and method of using the same |
| 12/30/2010 | US20100331369 Therapeutic Agents Useful for Treating Pain |
| 12/30/2010 | US20100331367 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 12/30/2010 | US20100331361 Pharmaceutical composition containing alpha-adrenergic receptor antagonist and an anti-muscarinic agent and method of improving lower urinary tract symptoms associated with prostatic hypertrophy |
| 12/30/2010 | US20100331346 Beta-amino acid derivatives for treatment of diabetes |
| 12/30/2010 | US20100331343 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 12/30/2010 | US20100331338 Glucokinase Activators |
| 12/30/2010 | US20100331304 Compounds Which Modulate The CB2 Receptor |
| 12/30/2010 | US20100331270 Adrenomedullin production enhancer |
| 12/30/2010 | US20100331268 Nitrated Lipids and Methods of Making and Using Thereof |
| 12/30/2010 | US20100331265 Methods for the prevention and treatment of burn injuries and secondary complications |
| 12/30/2010 | US20100330673 Methods of making enhanced, autologous fat grafts |
| 12/30/2010 | US20100330175 Cross-linked polyallylamine tablet core |
| 12/30/2010 | US20100330149 Solid Drug Tablets for Implantable Drug Delivery Devices |
| 12/30/2010 | US20100330072 Myostatin binding agents |
| 12/29/2010 | WO2010150899A1 Novel thiophene carboxamide derivative and medicinal use of same |
| 12/29/2010 | WO2010150865A1 Crystals |
| 12/29/2010 | WO2010150840A1 N-substituted-cyclic amino derivative |
| 12/29/2010 | WO2010150525A1 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug |
| 12/29/2010 | WO2010149634A1 Novel indole, indazole and benzimidazole arylamides as p2x3 and/or p2x2/3 antagonists |
| 12/29/2010 | WO2010078324A3 Companion animal compositions including lipoic acid and methods of use thereof |
| 12/29/2010 | EP2267026A1 Albumin fusion proteins |
| 12/29/2010 | EP2266577A1 Multi-substitued selective androgen receptor modulators and methods of use therof |
| 12/29/2010 | EP2266575A2 Use of Norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels |
| 12/29/2010 | EP2266571A1 Pharmaceutical combinations for treating lower urinary tract disfunctions |
| 12/29/2010 | EP2266568A1 Use of LHRH antagonists in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders |
| 12/29/2010 | EP2266567A1 Use of cetrorelix in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders |
| 12/29/2010 | EP2265612A1 Substituted xanthine derivatives |
| 12/29/2010 | EP2265610A1 Pyrazole [3, 4-b]pyridine raf inhibitors |
| 12/29/2010 | EP2265609A1 Imdizo [4. 5-b] pyridine derivatives used as raf inhibitors |
| 12/29/2010 | EP2265602A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases |
| 12/29/2010 | EP2265334A2 Substituted xanthine derivatives |
| 12/29/2010 | EP1576959B1 Softgel of nlkj (neutral lipids obtained from kernels of job's tears) for treating prostate diseases |
| 12/29/2010 | EP1529062B1 Therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction |
| 12/29/2010 | EP1494705B1 A composition and method for killing of tumours |
| 12/29/2010 | EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 12/29/2010 | EP1107722B1 A method for the treatment of staphylococcal infection |
| 12/29/2010 | CN1929861B CTGF as target for the therapy of diabetic nephropathy |
| 12/29/2010 | CN1922139B Bicyclic amide derivatives |
| 12/29/2010 | CN101928287A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 12/29/2010 | CN101928244A Structural analogue and derivative of isochromanone-4 compound with cardiovascular activity, preparation method and application thereof |
| 12/29/2010 | CN101926936A Tibetan medicinal health-care product |
| 12/29/2010 | CN101926863A Method for identifying Nigella glandulifera Freyn medicinal material |
| 12/29/2010 | CN101926823A Penetrating agent used for peritoneal dialysate and dialysate thereof |
| 12/29/2010 | CN101926803A Application of quinazoline compounds |
| 12/29/2010 | CN101926802A Application of quinazoline compounds |
| 12/29/2010 | CN101926795A Medicinal composition for treating hyperur icemia |
| 12/29/2010 | CN101926794A Medicinal composition for treating gout |
| 12/29/2010 | CN101926789A Improved topical medicaments and methods for photodynamic treatment of disease |
| 12/29/2010 | CN101926788A Cardiovascular/cerebral and ophthalmological medicines, and preparation and use thereof |
| 12/29/2010 | CN101926781A Solid medicinal composition of oxapium iodide |
| 12/29/2010 | CN101926464A Preparation method of medicament vinegar egg |
| 12/29/2010 | CN101926396A Method for preparing Chinese medicinal bagged tea |
| 12/29/2010 | CN101658644B Internal administration medicament for treating urolithiasis disease |
| 12/29/2010 | CN101445504B Dioxane-2-alkyl carbamates derivatives |
| 12/29/2010 | CN101417132B Use of medicine combination comprising carvedilol and angiotensin II recipient antagonist in preparing medicine for treating kidney disease |
| 12/29/2010 | CN101229301B Chinese traditional medicine compounds for treating urinary system infection and prostatitis |
| 12/29/2010 | CN101142193B Propane-1,3-dion derivative or salt thereof |
| 12/29/2010 | CA2784286A1 Urate transporter, method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug |
| 12/29/2010 | CA2766387A1 Novel thiophenecarboxamide derivative and pharmaceutical use thereof |
| 12/29/2010 | CA2764475A1 Crystals |
| 12/29/2010 | CA2761921A1 Novel indole, indazole and benzimidazole arylamides |
| 12/28/2010 | US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them |
| 12/28/2010 | US7858806 hydrolyzing the brominated product of 1-methylhydantoin to form 5-hydroxy-1-methylimidazolidin-2,4-dione, drug such as for renal failure; purified product for renal patients |